The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome
Autor(es) y otros:
Fecha de publicación:
Versión del editor:
Citación:
ISSN:
Patrocinado por:
This research was funded by the European Union’s Seventh Framework Programme through the Blueprint Consortium (grant agreement 282510); the European Research Council under the European Union’s Horizon 2020 research and innovation program (Project BCLLATLAS, grant agreement 810287). Ministerio de Ciencia, Innovación y Universidades of the Spanish Government, grants RTI2018-094274-B-I00 (to E.C.) and SAF2017-86126-R (to J.I.M.-S.). Proyecto Medicina Personalizada PERMED (grant PMP15/00007), which is part of Plan Nacional de I+D+I and is cofinanced by the ISCIII-Sub-Directorate General for Evaluation and the European Regional Development Fund (FEDER; “Una manera de Hacer Europa”); CIBERONC (CB16/12/00225, CB16/12/00334, CB16/12/00236 and CB16/12/00489);research funding from Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III PI17/01061 (S.B.); Ministerio de Ciencia, Innovación y Universidades, RTI2018-094274-B-I00, SAF2015-64885-R (E.C.); NIH grant number 1P01CA229100 (E.C.) and the European Regional Development Fund “Una manera de fer Europa”, CERCA Programme/Generalitat de Catalunya. F.N. is supported by a predoctoral fellowship of the Ministerio de Economía y Competitividad (MINECO, BES-2016-076372)
Colecciones
- Artículos [37127]